[Elsevier] Subcutaneous versus intravenous pembrolizumab, in combination with chemotherapy, for treatment of metastatic non-small-cell lung cancer: the phase III 3475A-D77 trial

icarus Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-06-23 03:12

Reward10points

journal：Annals of Oncology

Authors：E. Felip; C.I. Rojas; M. Schenker; D.M. Kowalski; I.A. Casarini; T. Csszi; M.A.N. endur; J. Martins; A. Calles Blanco; C.-C. Wang; M. Wang; R.A.L. Ramirez Fallas; H. Yoshioka; S. Nair; X. Song; X. Deng; M. Lala; R. Eiras; T. Takahashi

Published date：2025-7-

DOI：10.1016/j.annonc.2025.03.012

PDF link：https://www.sciencedirect.com/sc ... 923753425001231/pdf

Article link：https://doi.org/10.1016/j.annonc.2025.03.012

Article Source：Elsevier BV。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report